drugIndia
Cart
Glimulin MV 1 Tablet ER

Glimulin MV 1 Tablet ER

Glimepiride (1mg) + Voglibose (0.2mg) + Metformin (500mg)

Glenmark Pharmaceuticals Ltd
Anti-Vomiting
96.75120.9420% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 67%
Best Alternative100% Match

Glimison-VM 1 Tablet SR

Unison Pharmaceuticals Pvt Ltd

Voglibose 0.2mg
Glimison-VM 1 Tablet SR

Pack Size

1 units

Price

31.6020% off
Glimison-VM 1 Tablet SR is 100% same as Glimulin MV 1 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹65

that's 67% off!

composition
  1. Voglibose 0.2mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
96.7520% OFF
120.94

About This Medicine

Product description & overview

Glimulin MV 1 Tablet ER: A Combined Solution for Type 2 Diabetes Management

Glimulin MV 1 Tablet ER is a once-daily combination medication prescribed to manage type 2 diabetes mellitus. This extended-release tablet delivers three active ingredients in precise dosages: glimepiride (1mg), metformin (500mg), and voglibose (0.2mg).

Glimulin MV 1 Tablet ER works by targeting multiple mechanisms to improve blood sugar control:
* Glimepiride: This sulfonylurea promotes insulin release from the pancreas, effectively reducing glucose levels in the body.
* Metformin: A biguanide that helps cells utilize glucose for energy, decreasing glucose production in the liver.
* Voglibose: A selective α-glucosidase inhibitor that slows down the absorption of carbohydrates, further controlling postprandial blood sugar spikes.

This combined formulation offers convenient once-daily dosing and enhanced control over blood glucose levels, improving both short-term and long-term management of type 2 diabetes.

Consult your healthcare provider for appropriate dosage and administration instructions.

Active composition

Glimepiride 1 mg

+2 more active ingredients

About Glimepiride

Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.

How It Works

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Medicine Strength
1 mg

All Active Ingredients

Glimepiride1 mg
Voglibose0.2 mg
Metformin500 mg

Voglibose

Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.

Metformin

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimulin MV 1 Tablet ER.

High Risk

Pregnancy

Glimulin MV 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimulin MV 1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimulin MV 1 Tablet ER may be needed. Please consult your doctor. Glimulin MV 1 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimulin MV 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimulin MV 1 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimulin MV 1 Tablet ER is, however, not recommended in patients with severe kidney disease.

Regular Checkup

Customer Reviews

0 reviews for Glimulin MV 1 Tablet ER

Products matching your search